Digest 9/28/23
Surveying great inventors and businesses
Axial: https://linktr.ee/axialxyz
Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio, Seranova Bio, Delix Therapeutics, Simcha Therapeutics, among others often when they are no more than an idea. We are fanatical about helping the rare inventor who is compelled to build their own enduring business. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company . We are excited to be in business with you - email us at info@axialvc.com
Switchable DNA Catalysts for Proximity Labeling at Sites of Protein–Protein Interactions led by Ashley Ogorek from the Jeffrey Martell lab https://pubs.acs.org/doi/full/10.1021/jacs.3c05578
Vault: Cell reprogramming
Harbinger Health raised $140M led by Flagship Pioneering. To build a screening platform for early-stage cancers and complete clinical validation of its blood-based cancer screening product. With an anticipated 2025 product launch, to support the completion of its Cancer ORigin Epigenetics-Harbinger Health (CORE-HH) 10,000-participant clinical study. Founded in 2018, Harbinger detects early cancer with a blood test that combines molecular diagnostic and machine learning.
Scientist Stories: James Crowe, Monoclonal Antibodies for Infectious Diseases
"We never fire scientists when a program fails. [Vertex always pursues] a portfolio of drugs for a disease. We move them all forward at once"
- Jeffrey Leiden, former CEO and President of Vertex Pharmaceuticals
